Targeting binding function-3 site on the androgen receptor to treat Enzalutamide-resistant prostate cancer

被引：0
|
作者：
Munuganti, Ravi Shashi Nayana [1 ]
Hassona, Mohamed D. H. [1 ]
Leblanc, Eric [1 ]
Guns, Emma T. [1 ]
Rennie, Paul S. [1 ]
Cherkasov, Artem [1 ]
机构：
[1] Vancouver Prostate Ctr, Vancouver, BC, Canada
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3654
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer
    Munuganti, Ravi S. N.
    Hassona, Mohamed D. H.
    Leblanc, Eric
    Frewin, Kate
    Singh, Kriti
    Ma, Dennis
    Ban, Fuqiang
    Hsing, Michael
    Adomat, Hans
    Lallous, Nada
    Andre, Christophe
    Jonadass, Jon Paul Selvam
    Zoubeidi, Amina
    Young, Robert N.
    Guns, Emma Tomlinson
    Rennie, Paul S.
    Cherkasov, Artem
    CHEMISTRY & BIOLOGY, 2014, 21 (11): : 1476 - 1485
  • [2] Discovery of novel biphenyl derivatives as androgen receptor degraders for the treatment of enzalutamide-resistant prostate cancer
    Zhang, Wenqiang
    Fan, Yawen
    Zhang, Yan
    Feng, Yunrui
    Luo, Yi
    Zhou, Xiaoyu
    Chen, Zhuolin
    Wang, Chenxiao
    Lu, Tao
    Tang, Feng
    Chen, Yadong
    Li, Hongmei
    Jiao, Yu
    BIOORGANIC CHEMISTRY, 2024, 148
  • [3] Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants
    Banuelos, Carmen A.
    Ito, Yusuke
    Obst, Jon K.
    Mawji, Nasrin R.
    Wang, Jun
    Hirayama, Yukiyoshi
    Leung, Jacky K.
    Tam, Teresa
    Tien, Amy H.
    Andersen, Raymond J.
    Sadar, Marianne D.
    CANCERS, 2020, 12 (07) : 1 - 17
  • [4] Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants
    Shiota, Masaki
    Dejima, Takashi
    Yamamoto, Yoshiaki
    Takeuchi, Ario
    Imada, Kenjiro
    Kashiwagi, Eiji
    Inokuchi, Junichi
    Tatsugami, Katsunori
    Kajioka, Shunichi
    Uchiumi, Takeshi
    Eto, Masatoshi
    CANCER SCIENCE, 2018, 109 (10) : 3224 - 3234
  • [5] Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth
    Yamamoto, Yoshiaki
    Loriot, Yohann
    Beraldi, Eliana
    Zhang, Fan
    Wyatt, Alexander W.
    Al Nakouzi, Nader
    Mo, Fan
    Zhou, Tianyuan
    Kim, Youngsoo
    Monia, Brett P.
    MacLeod, A. Robert
    Fazli, Ladan
    Wang, Yuzhuo
    Collins, Colin C.
    Zoubeidi, Amina
    Gleave, Martin
    CLINICAL CANCER RESEARCH, 2015, 21 (07) : 1675 - 1687
  • [6] Aryl hydrocarbon receptor is critical for enzalutamide-resistant prostate cancer growth
    Chen, Chia-Hui
    Wu, Boyang Jason
    CANCER RESEARCH, 2023, 84 (06)
  • [7] Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer
    Ponnusamy, Suriyan
    He, Yali
    Hwang, Dong-Jin
    Thiyagarajan, Thirumagal
    Houtman, Rene
    Bocharova, Vera
    Sumpter, Bobby G.
    Fernandez, Elias
    Johnson, Daniel
    Du, Ziyun
    Pfeffer, Lawrence M.
    Getzenberg, Robert H.
    McEwan, Iain J.
    Miller, Duane D.
    Narayanan, Ramesh
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 6764 - 6780
  • [8] Minnelide reduces castration-resistant and enzalutamide-resistant prostate cancer via downregulation of androgen receptor-mediated signaling
    Isharwal, Sumit
    Modi, Shrey
    Barlass, Usman
    Dudeja, Vikas
    Saluja, Ashok
    Banerjee, Sulagna
    Konety, Badrinath
    CANCER RESEARCH, 2015, 75
  • [9] MCT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE
    Bhattacharjee, Sayani
    Wynn, Rebecca
    Sindhwani, Puneet
    Petros, Firas
    Nadiminty, Nagalakshmi
    JOURNAL OF UROLOGY, 2023, 209 : E146 - E146
  • [10] Targeting adenocarcinoma and enzalutamide-resistant prostate cancer using the novel anti-androgen inhibitor ADA-308
    Nouruzi, Shaghayegh
    Johnson, Fraser
    Kumar, Sahil
    Sivak, Olena
    Tabrizian, Nakisa
    Koistinaho, Milla
    Muona, Anu
    Zoubeidi, Amina
    ONCOLOGY REPORTS, 2024, 52 (04)
12345